76 related articles for article (PubMed ID: 7212743)
1. Scale prophylaxis. A new antiparakeratotic assay.
Wrench R
Arch Dermatol; 1981 Apr; 117(4):213-5. PubMed ID: 7212743
[TBL] [Abstract][Full Text] [Related]
2. Topical psoriasis therapy.
Federman DG; Froelich CW; Kirsner RS
Am Fam Physician; 1999 Feb; 59(4):957-62, 964. PubMed ID: 10068717
[TBL] [Abstract][Full Text] [Related]
3. Managing a common disorder in children: Atopic dermatitis.
Cheigh NH
J Pediatr Health Care; 2003; 17(2):84-8; quiz 89-90. PubMed ID: 12665731
[No Abstract] [Full Text] [Related]
4. Comparative effects of calcipotriol ointment (50 micrograms/g) and 5% coal tar/2% allantoin/0.5% hydrocortisone cream in treating plaque psoriasis.
Pinheiro N
Br J Clin Pract; 1997; 51(1):16-9. PubMed ID: 9158266
[TBL] [Abstract][Full Text] [Related]
5. [Question of the month: should coal-tar be forbidden?].
Ann Dermatol Venereol; 1997; 124(2):205-7. PubMed ID: 9740840
[No Abstract] [Full Text] [Related]
6. A comparative study of tar and betamethasone valerate in chronic plaque psoriasis: a study in Thailand.
Thawornchaisit P; Harncharoen K
J Med Assoc Thai; 2007 Oct; 90(10):1997-2002. PubMed ID: 18041415
[TBL] [Abstract][Full Text] [Related]
7. Understanding psoriasis and the treatment options.
Freak J
Nurs Times; 2006 Jun 27-Jul 3; 102(26):47, 49. PubMed ID: 16845819
[No Abstract] [Full Text] [Related]
8. [Results of the treatment of superficial hyperkeratotic lesions with Solcoderm].
Rogoziński T; Szymańczyk J; Jabłońska S
Przegl Dermatol; 1984; 71(3):287-90. PubMed ID: 6395199
[No Abstract] [Full Text] [Related]
9. Helping people to remain in control of their psoriasis.
Watts J
Community Nurse; 1998 Aug; 4(7):19-21. PubMed ID: 9763988
[TBL] [Abstract][Full Text] [Related]
10. Regarding laser resurfacing-induced hypopigmentation.
Urbanek RW
Dermatol Surg; 2001 Oct; 27(10):914. PubMed ID: 11722538
[No Abstract] [Full Text] [Related]
11. Evaluation of coal tar fractions for use in psoriasiform diseases using the mouse tail test. (II) Tar oil acids.
Wrench R; Britten AZ
Br J Dermatol; 1975 May; 92(5):575-9. PubMed ID: 1174470
[TBL] [Abstract][Full Text] [Related]
12. Three-way therapeutic effectiveness of tar-steroid cream.
WELSH AL; EDE M
J Am Med Assoc; 1958 Jan; 166(2):158-9. PubMed ID: 13491323
[No Abstract] [Full Text] [Related]
13. Treatment policy for psoriasis and eczema: a survey among dermatologists in the Netherlands and Belgian Flanders.
Roelofzen JH; Aben KK; Khawar AJ; Van de Kerkhof PC; Kiemeney LA; Van Der Valk PG
Eur J Dermatol; 2007; 17(5):416-21. PubMed ID: 17673386
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of subacute & chronic dermatosis with coal tar ointment & hydrocortisone].
BLEIBERG J
Arch Med Cuba; 1957; 8(3):135-9. PubMed ID: 13459723
[No Abstract] [Full Text] [Related]
15. Two new retinoids for psoriasis.
Med Lett Drugs Ther; 1997 Nov; 39(1013):105-6. PubMed ID: 9391501
[No Abstract] [Full Text] [Related]
16. The benefits of switching to nurse-led management of patients with psoriasis.
Riddoch C
Prof Nurse; 2005 Jan; 20(5):38-40. PubMed ID: 15682996
[TBL] [Abstract][Full Text] [Related]
17. New drug information. Acanya.
JAAPA; 2009 Apr; 22(4):12. PubMed ID: 19452815
[No Abstract] [Full Text] [Related]
18. Evaluation of coal tar fractions for use in psoriasiform diseases using the mouse tail test. III. High boiling tar oil acids.
Wrench R; Britten AZ
Br J Dermatol; 1975 Jul; 93(1):67-74. PubMed ID: 1191530
[TBL] [Abstract][Full Text] [Related]
19. Tazarotene (tazorac) for acne.
Med Lett Drugs Ther; 2002 Jun; 44(1132):52-3. PubMed ID: 12058150
[No Abstract] [Full Text] [Related]
20. Current systemic therapies for psoriasis: where are we now?
Yamauchi PS; Rizk D; Kormeili T; Patnaik R; Lowe NJ
J Am Acad Dermatol; 2003 Aug; 49(2 Suppl):S66-77. PubMed ID: 12894129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
